NFKB1 and colitis: In a mice model of colitis, supplementation with penta-O-galloyl-β-D-glucose inhibited colon shortening and myeloperoxidase activity, reduced the activation of NF-κB and levels of IL-1β, TNF-α, and IL-6, but increased IL-10 levels [99].